What is INNPF's gross margin?

INNOCAN PHARMA (INNPF) has a gross margin of 91% and a net margin of -1%.

What is INNPF's P/E ratio?

Track INNOCAN PHARMA (INNPF) P/E ratio, ROE, and valuation metrics over time.

Where can I see INNPF's full financials?

See INNOCAN PHARMA (INNPF) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

INNOCAN PHARMA (INNPF) Financials — Revenue, Earnings, Cash Flow

$1.40

-0.22 (-13.58%)

OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 37 · $6.3M mcap · 4M float · 0.0019% daily turnover · Short 82% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$23M

Revenue

-19.2% YoY

$-1M

Net Income

+40.1% YoY

$-2M

Free Cash Flow

-225.8% YoY

90.8%

Gross Margin

-9.7%

Op. Margin

-0.6%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-21.0%

ROA-8.8%

ROIC-13488.5%

Valuation

P/E-7.4

P/B1.4

EV/EBITDA-2.8

Leverage

Debt/Equity0.35

Current Ratio4.99

Interest Cov.-43.7x

Quality Scores

Piotroski F3/9

Altman Z-0.61

Beneish M-1.73